Systemic therapy in the management of metastatic or advanced salivary gland cancers

Area of Science:

• Oncology
• Cancer Research
• Head and Neck Cancers

Background:

• Salivary gland cancers are rare, heterogeneous tumors with poor outcomes.
• Limited prospective data exist, hindering standardized treatment recommendations.
• Systemic therapy options for these cancers are not well-established.

Purpose of the Study:

• To comprehensively review existing literature on systemic therapies for salivary gland cancers.
• To evaluate the role of chemotherapy, targeted therapy, and hormone therapy.
• To provide an overview of treatment strategies for these rare malignancies.

Main Methods:

• Exhaustive literature search of studies investigating systemic therapies.
• Inclusion of case reports and small studies.
• Analysis of research on chemotherapy, targeted therapy, and hormone therapy.

Main Results:

• Chemotherapy has been investigated in several small studies and case reports.
• Targeted therapies are emerging, driven by discoveries in cancer signaling pathways.
• Hormone therapy has also been explored as a potential treatment modality.

Conclusions:

• Systemic therapy for salivary gland cancers remains an area with limited evidence.
• Further research is needed to establish standardized treatment protocols.
• Targeted therapies show promise but require more investigation in this rare cancer type.